Wednesday, February 10, 2010, 4:18pm SGT - The Singapore stock market closes in 42 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

XOMA Ltd. (XOMA)

At 5:00AM SGT: 0.415 USD   0.00 (0.00%)  
 MORE ON XOMA 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 XOMA Ltd. (NGM:XOMA) Delayed quote dataEdit
Last Trade:0.415 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:0.415
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.73
Day's Range:N/A - N/A
52wk Range:0.37 - 1.34
Volume:0
Avg Vol (3m):3,067,920
Market Cap:82.56M
P/E (ttm):8.14
EPS (ttm):0.051
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add XOMA to Portfolio   Download Data

 HEADLINES 
•XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 Diabetes Patients
GlobeNewswire (Tue 8:00pm)
•XOMA Announces Presentation at BIO CEO and Investor Conference on February 9
GlobeNewswire (Thu, Feb 4)
•XOMA LTD /DE/ Files SEC form 8-K/A, Financial Statements and Exhibits
EDGAR Online (Thu, Feb 4)
•Liberty Analytics Co. Initiates Independent Research Coverage on XOMA Ltd.
GlobeNewswire (Wed, Feb 3)
•Xoma to raise $21M via stock, warrants
at bizjournals.com (Wed, Feb 3)
•Xoma offering $21 million in stock and warrants
AP (Wed, Feb 3)
•Medivation's Alzheimer Trial Data in Early March: Biobuzz
at TheStreet.com (Tue, Feb 2)
•XOMA LTD /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Feb 2)
•XOMA Announces $21 Million Underwritten Offering of Common Shares and Warrants
GlobeNewswire (Tue, Feb 2)
•XOMA Reviews Priorities for 2010 and 2009 Accomplishments
GlobeNewswire (Tue, Jan 19)
More Headlines for XOMA...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.05
EPS Est (in 2 years) (Dec-10) :-0.13
Avg Rec (current)*:1.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
XOMA Ltd., a biopharmaceutical company, engages in the discovery, development, and manufacture of therapeutic antibodies and other agents to treat inflammatory, autoimmune, infectious, and oncological diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices